The UK Swiss Innovation Forum is taking place on 29 June at the main campus of the Switzerland Innovation Park Basel. The Forum's objective is to identify barriers to and opportunities for closer collaboration between UK and Swiss Life Sciences innovation ecosystems and communities.
The Forum will involve "end to end" innovation representatives from industry, academia, government, investment and the start-up community. There will be a number of keynote speeches and panel discussions, with participants also able to discuss ways forward in interactive workshops. This interactive forum will provide plenty of networking opportunities and give stakeholders a voice to suggest and discuss ways of intensifying cross-border collaboration.
Speakers include representatives from the following organisations:
AstraZeneca, GSK, Novartis NIBR, Smith & Nephew, ABHI, Oxford University, Imperial College London, University of Basel, University of Edinburgh, Medicines Discovery Catapult, STFC, University UK International, Innosuisse, Innovate UK, SERI, DSIT, Switzerland Innovation, Redalpine Venture Partners, Spexx Capital, Business Angels Switzerland, The Life Sciences Division, Swiss Medtech
The Forum will open with a session featuring government representatives, funding agencies and innovation hubs, setting out the respective innovation landscapes and opportunities for international collaboration.
Industry, investor and university innovation panels will then discuss how companies and universities in both countries can take advantage of our strong Life Sciences sectors. In the afternoon, implementation workshops will provide the opportunity to share inputs on how to unlock opportunities in the key areas of Medtech, Drug Development and Bioinformatics.
Please visit the following link for more information and to register for the event: https://www.eventbrite.co.uk/e/uk-swiss-life-sciences-innovation-forum-tickets-634043239397